Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium

被引:13
|
作者
Marth, C
Windbichler, G
Petru, E
Dirschlmayer, W
Obermair, A
Czerwenka, K
MullerHolzner, E
Dapunt, O
机构
[1] UNIV INNSBRUCK HOSP,DEPT OBSTET & GYNECOL,INNSBRUCK,AUSTRIA
[2] UNIV HOSP,DEPT OBSTET & GYNECOL,GRAZ,AUSTRIA
[3] UNIV HOSP,DEPT OBSTET & GYNECOL,VIENNA,AUSTRIA
[4] HOSP BARMHERZIGEN SCHWESTERN,LINZ,AUSTRIA
关键词
MULLERIAN TUMORS; UTERUS;
D O I
10.1006/gyno.1996.4538
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant mixed mesodermal tumors (MMMT) are the most malignant neoplasms known to occur in the uterus. The most important prognostic factors are the extent of tumor at diagnosis, depth of myometrial invasion, and, as regarded by some authors, the sarcomatous component, We report on a retrospective analysis in 83 patients with MMMT. By univariate analysis survival was dependent on stage, depth of myometrial invasion, kind of therapy, age at menopause, and parity. However, the sarcomatous component did not significantly influence survival. Using the multivariate Cox regression analysis stage and parity or depth of myometrial invasion and parity were found to independently predict prognosis. Despite an interval of more than 20 years from the last childbirth to tumor appearance a beneficial influence of parity on the prognosis of MMMT was identified. This is unique in oncology. Especially patients with more than three children formed a subgroup of long-term survivors. It is interesting to note that parity was found by means of a Cox regression analysis to be statistically independent, and no correlation with other classical prognostic factors was detected. (C) 1997 Academic Press
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条
  • [41] MIXED MESODERMAL TUMORS OF UTERUS
    PEREZ, CA
    ASKIN, F
    WIESS, D
    KAO, MS
    KRAUS, F
    WILLIAMS, C
    PEREZ, BM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1976, : 118 - 119
  • [42] The carcinomatous ratio in malignant mixed mesodermal tumours: Its prognostic implications.
    Abdulkader, M
    Kamel, HMH
    Harrison, D
    Al-Nafussi, A
    JOURNAL OF PATHOLOGY, 2001, 193 : 35A - 35A
  • [43] The Use of Machine Learning to Analyze the Features of Endometrial Malignant Mesodermal Mixed Tumors
    Kaplan, A.
    Shiao, H-T
    Jackson, S.
    Dickson, E. L.
    Jonson, A. L.
    Cherkassky, V.
    Truskinovsky, A. M.
    MODERN PATHOLOGY, 2014, 27 : 400A - 400A
  • [44] EXTRAUTERINE PELVIC MALIGNANT MIXED MESODERMAL TUMORS - A STUDY OF 10 CASES WITH IMMUNOHISTOCHEMISTRY
    DELIGDISCH, L
    PLAXE, S
    COHEN, CJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1988, 7 (04) : 361 - 372
  • [45] The Use of Machine Learning to Analyze the Features of Endometrial Malignant Mesodermal Mixed Tumors
    Kaplan, A.
    Shiao, H-T
    Jackson, S.
    Dickson, E. L.
    Jonson, A. L.
    Cherkassky, V.
    Truskinovsky, A. M.
    LABORATORY INVESTIGATION, 2014, 94 : 400A - 400A
  • [46] PLATINUM-BASED COMBINATION CHEMOTHERAPY FOR MALIGNANT MIXED MESODERMAL TUMORS OF THE OVARY
    ANDERSEN, WA
    YOUNG, DE
    PETERS, WA
    SMITH, EB
    BAGLEY, CM
    TAYLOR, PT
    GYNECOLOGIC ONCOLOGY, 1989, 32 (03) : 319 - 322
  • [47] MALIGNANT MESODERMAL (MESENCHYMAL) TUMORS OF BLADDER
    SAVIR, A
    MEIRAZ, D
    UROLOGY, 1980, 16 (03) : 307 - 309
  • [48] Malignant mesodermal mixed tumor of the ureter
    Hashimoto, Y
    Iwase, Y
    Mogami, T
    Tsugaya, M
    Kohri, K
    UROLOGIA INTERNATIONALIS, 1998, 60 (02) : 118 - 120
  • [49] MALIGNANT MIXED MESODERMAL TUMOR OF UTERUS
    THURNER, J
    MONTANO, A
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1977, 127 (07) : 232 - 236
  • [50] MALIGNANT MIXED MESODERMAL TUMOR OF OVARY
    GROVER, V
    DHALL, K
    GROVER, RK
    CHOUDHRY, T
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1985, 20 (04) : 241 - 246